125 related articles for article (PubMed ID: 23784708)
1. Design of a highly selective and potent class of non-planar estrogen receptor β agonists.
Sundén H; Ma JN; Hansen LK; Gustavsson AL; Burstein ES; Olsson R
ChemMedChem; 2013 Aug; 8(8):1283-94. PubMed ID: 23784708
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
6. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
[TBL] [Abstract][Full Text] [Related]
9. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design.
Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Schneider B; Reddersen G; Elger W; Fritzemeier KH
Mol Endocrinol; 2004 Jul; 18(7):1599-609. PubMed ID: 15105439
[TBL] [Abstract][Full Text] [Related]
10. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.
Richardson TI; Dodge JA; Wang Y; Durbin JD; Krishnan V; Norman BH
Bioorg Med Chem Lett; 2007 Oct; 17(20):5563-6. PubMed ID: 17804226
[TBL] [Abstract][Full Text] [Related]
11. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
[TBL] [Abstract][Full Text] [Related]
12. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
[TBL] [Abstract][Full Text] [Related]
13. ERα-agonist and ERβ-antagonist bifunctional next-generation bisphenols with no halogens: BPAP, BPB, and BPZ.
Liu X; Matsuyama Y; Shimohigashi M; Shimohigashi Y
Toxicol Lett; 2021 Jul; 345():24-33. PubMed ID: 33857583
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
McDevitt RE; Malamas MS; Manas ES; Unwalla RJ; Xu ZB; Miller CP; Harris HA
Bioorg Med Chem Lett; 2005 Jun; 15(12):3137-42. PubMed ID: 15876535
[TBL] [Abstract][Full Text] [Related]
17. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
18. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
[TBL] [Abstract][Full Text] [Related]
19. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
